Description
Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist studied for its effects on metabolic signalling, glucose regulation and body-weight control. By targeting two incretin pathways at once, it has attracted significant research interest in appetite regulation, insulin sensitivity and energy balance.
Areas of Research Interest
Tirzepatide is being investigated in relation to:
- Body-weight reduction and appetite regulation
- Glucose control and insulin sensitivity
- Satiety and reduced energy intake
- Body-composition changes
- Lipid metabolism and cardiometabolic markers
- Type 2 diabetes and obesity-related metabolic pathways
Tides Tirzepatide is supplied as a lyophilised research-grade powder, with independent batch testing used to verify identity and purity.
Product information:
- Tirzepatide
- Dual GIP/GLP-1 receptor agonist
- Lyophilised powder
- Purity >99%
- Independently batch tested
- Certificate of Analysis available
- UK dispatched
- For research use only
Reviews
There are no reviews yet.